News

Search here results

• Brain shrinkage associated with Alzheimer’s therapies shows effectiveness rather than harm | UCL Queen Square Institute of Neurology - UCL – University College London
• Mace appointed to complete UCL's world-class neuroscience centre | UCL Queen Square Institute of Neurology - UCL – University College London
• Researchers to untangle scientific link between air pollution and dementia | UCL Queen Square Institute of Neurology - UCL – University College London
• £5m gift extends Sigrid Rausing Trust support for neurodegenerative disease research at UCL | UCL Queen Square Institute of Neurology - UCL – University College London
• New Study to Address Persistent Inequalities in Dementia Services for Black Communities in the UK | Psychiatry - UCL – University College London
• More diversity needed in dementia studies to enhance targeted therapies | UCL Queen Square Institute of Neurology - UCL – University College London
• Dementia Researcher Communities: A New Platform for Career Support and Global Collaboration. | UCL Queen Square Institute of Neurology - UCL – University College London
• 'Momentous occasion': UCL experts greet first drug approved for early Alzheimer’s disease in the UK | UCL Queen Square Institute of Neurology - UCL – University College London
• UCLIC behavioural scientist explores barriers to dementia research | UCLIC - UCL Interaction Centre - UCL – University College London
• Supporting brain cell a key driver of harmful protein production in Alzheimer’s | UCL Queen Square Institute of Neurology - UCL – University College London